UBS Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Sell |
1,779,412
-717,337
| -29% | -$1.23M | ﹤0.01% | 3471 |
|
|
2025
Q1 | $8.31M | Sell |
2,496,749
-207,720
| -8% | -$692K | ﹤0.01% | 2536 |
|
|
2024
Q4 | $20M | Buy |
2,704,469
+2,082,340
| +335% | +$15.4M | ﹤0.01% | 1760 |
|
|
2024
Q3 | $5.84M | Sell |
622,129
-173,075
| -22% | -$1.63M | ﹤0.01% | 2142 |
|
|
2024
Q2 | $6.38M | Buy |
795,204
+104,324
| +15% | +$837K | ﹤0.01% | 1923 |
|
|
2024
Q1 | $10.2M | Sell |
690,880
-166,428
| -19% | -$2.47M | ﹤0.01% | 1596 |
|
|
2023
Q4 | $6.97M | Buy |
857,308
+615,920
| +255% | +$5.01M | ﹤0.01% | 1708 |
|
|
2023
Q3 | $1.1M | Sell |
241,388
-228,424
| -49% | -$1.04M | ﹤0.01% | 3002 |
|
|
2023
Q2 | $3.31M | Buy |
469,812
+42,993
| +10% | +$303K | ﹤0.01% | 2249 |
|
|
2023
Q1 | $2.61M | Sell |
426,819
-370,863
| -46% | -$2.27M | ﹤0.01% | 2362 |
|
|
2022
Q4 | $5.1M | Buy |
797,682
+691,443
| +651% | +$4.42M | ﹤0.01% | 1826 |
|
|
2022
Q3 | $1.02M | Buy |
106,239
+11,600
| +12% | +$111K | ﹤0.01% | 2841 |
|
|
2022
Q2 | $1.05M | Sell |
94,639
-265,107
| -74% | -$2.93M | ﹤0.01% | 2860 |
|
|
2022
Q1 | $5.99M | Buy |
359,746
+140,209
| +64% | +$2.33M | ﹤0.01% | 1786 |
|
|
2021
Q4 | $4.19M | Buy |
219,537
+23,253
| +12% | +$444K | ﹤0.01% | 2252 |
|
|
2021
Q3 | $4.84M | Buy |
196,284
+133,742
| +214% | +$3.3M | ﹤0.01% | 2038 |
|
|
2021
Q2 | $1.63M | Sell |
62,542
-35,306
| -36% | -$918K | ﹤0.01% | 2889 |
|
|
2021
Q1 | $3.1M | Buy |
97,848
+12,219
| +14% | +$387K | ﹤0.01% | 2372 |
|
|
2020
Q4 | $3.97M | Buy |
85,629
+13,650
| +19% | +$633K | ﹤0.01% | 2051 |
|
|
2020
Q3 | $2.37M | Buy |
71,979
+26,685
| +59% | +$879K | ﹤0.01% | 2284 |
|
|
2020
Q2 | $1.24M | Buy |
45,294
+17,495
| +63% | +$480K | ﹤0.01% | 2648 |
|
|
2020
Q1 | $832K | Sell |
27,799
-112,893
| -80% | -$3.38M | ﹤0.01% | 2803 |
|
|
2019
Q4 | $3.89M | Sell |
140,692
-235,229
| -63% | -$6.51M | ﹤0.01% | 2203 |
|
|
2019
Q3 | $6.84M | Buy |
375,921
+244,162
| +185% | +$4.44M | ﹤0.01% | 1625 |
|
|
2019
Q2 | $3.23M | Buy |
131,759
+121,504
| +1,185% | +$2.98M | ﹤0.01% | 2147 |
|
|
2019
Q1 | $98K | Sell |
10,255
-259,239
| -96% | -$2.48M | ﹤0.01% | 4300 |
|
|
2018
Q4 | $2.39M | Buy |
269,494
+223,833
| +490% | +$1.98M | ﹤0.01% | 2299 |
|
|
2018
Q3 | $513K | Buy |
45,661
+38,276
| +518% | +$430K | ﹤0.01% | 3612 |
|
|
2018
Q2 | $95K | Sell |
7,385
-53,837
| -88% | -$693K | ﹤0.01% | 4600 |
|
|
2018
Q1 | $1.04M | Buy |
61,222
+59,826
| +4,286% | +$1.01M | ﹤0.01% | 2996 |
|
|
2017
Q4 | $11K | Sell |
1,396
-6,604
| -83% | -$52K | ﹤0.01% | 5983 |
|
|
2017
Q3 | $62K | Sell |
8,000
-1,072
| -12% | -$8.31K | ﹤0.01% | 4761 |
|
|
2017
Q2 | $67K | Sell |
9,072
-15,928
| -64% | -$118K | ﹤0.01% | 4548 |
|
|
2017
Q1 | $186K | Sell |
25,000
-137,770
| -85% | -$1.03M | ﹤0.01% | 3853 |
|
|
2016
Q4 | $1.13M | Sell |
162,770
-130,238
| -44% | -$905K | ﹤0.01% | 2722 |
|
|
2016
Q3 | $2.41M | Buy |
293,008
+14,302
| +5% | +$118K | ﹤0.01% | 2086 |
|
|
2016
Q2 | $2.26M | Buy |
278,706
+1,991
| +0.7% | +$16.1K | ﹤0.01% | 2100 |
|
|
2016
Q1 | $1.41M | Sell |
276,715
-24,604
| -8% | -$125K | ﹤0.01% | 2412 |
|
|
2015
Q4 | $2.33M | Sell |
301,319
-56,681
| -16% | -$438K | ﹤0.01% | 2072 |
|
|
2015
Q3 | $2.06M | Buy |
358,000
+37,900
| +12% | +$218K | ﹤0.01% | 2118 |
|
|
2015
Q2 | $2.94M | Buy |
320,100
+116,600
| +57% | +$1.07M | ﹤0.01% | 2018 |
|
|
2015
Q1 | $2.46M | Buy |
+203,500
| New | +$2.46M | ﹤0.01% | 2142 |
|